Middle-class Indians trying to lose weight are embracing drugs such as Mounjaro, which is also used to treat diabetes in a ...
Eli Lilly and Company announced promising results for its next-generation weight-loss drug Thursday, with patients losing up ...
Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes.
This article was reviewed by Darragh O’Carroll, MD. Diabetes Medications for Weight Loss: What to Know Key takeaways: Some ...
Trump said his administration reached an agreement with Novo Nordisk and Eli Lilly to lower the cost of GLP-1 weight loss ...
More young people are being diagnosed with type 2 diabetes and the country is potentially facing a "major health crisis", ...
This article was reviewed by Lynn Marie Morski, MD, JD. Does Ozempic® Cause Bone Loss? Key takeaways: Taking Ozempic® may cause some bone density loss, but … ...
The deal is expected to lower the price of some obesity drugs to $149 per month in certain cases, according to reports.
Weight-loss drugs are booming (1) and you’ve probably heard of them: Wegovy, Ozempic, Mounjaro, Zepbound. These GLP-1 ...
Competition is working, even as the FTC meddles in a takeover fight in a way that helped Pfizer.
An experiment at the State University of Campinas found that FGF19, a substance produced in the intestine, acts on specific ...
Weight-loss drugs are booming (1) and you’ve probably heard of them: Wegovy, Ozempic, Mounjaro, Zepbound. These GLP-1 medications are helping Americans slim down and manage diabetes — and in some ...